Condition
Tenosynovial Giant Cell Tumor clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Tenosynovial Giant Cell Tumor clinical trials that are recruiting, at sites in 3 countries (most in China (2), United States (2), Japan (1)). By phase: Phase 4 (1), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Tenosynovial Giant Cell Tumor clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Pimicotinib for Japanese people with tenosynovial giant cell tumor (J-MANEUVER) | Phase 2 | Chūōku and 3 other locations | Recruiting | Mar 30, 2026 |
| Indocyanine green fluorescence imaging to visualize tenosynovial giant cell tumor during surgery. | Phase 4 | Shanghai | Recruiting | Jan 2, 2026 |
| Real-world experience with vimseltinib for tenosynovial giant cell tumor | — | Wilmington, North Carolina | Recruiting | Jul 20, 2025 |
| Assessing the safety and tolerability of ABSK-021 in patients with advanced solid tumors | Phase 1 | Beverly Hills, California and 16 other locations | Recruiting | Dec 10, 2019 |
All recruiting trials (4)
-
Pimicotinib for Japanese people with tenosynovial giant cell tumor (J-MANEUVER)
This trial will test whether pimicotinib is safe, reaches effective blood levels, and improves symptoms in Japanese participants with unresectable tenosynovial giant cell tumor.
-
Indocyanine green fluorescence imaging to visualize tenosynovial giant cell tumor during surgery.
This will test whether injecting indocyanine green helps surgeons see tumor tissue under near-infrared imaging in people having surgery for tenosynovial giant cell tumor.
-
Real-world experience with vimseltinib for tenosynovial giant cell tumor
This registry will collect real-world information about how people with TGCT take vimseltinib and how it affects their symptoms and quality of life.
-
Assessing the safety and tolerability of ABSK-021 in patients with advanced solid tumors
This study is testing a new oral medication called ABSK-021 to see if it's safe and tolerable for people with advanced solid tumors, especially those with tenosynovial giant cell tumor, who haven't had success with other treatments.
Related topics
Quick answers
How many Tenosynovial Giant Cell Tumor clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), United States (2 trials), Japan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.